Paul Gow

6.0k total citations
173 papers, 3.9k citations indexed

About

Paul Gow is a scholar working on Hepatology, Epidemiology and Surgery. According to data from OpenAlex, Paul Gow has authored 173 papers receiving a total of 3.9k indexed citations (citations by other indexed papers that have themselves been cited), including 115 papers in Hepatology, 86 papers in Epidemiology and 54 papers in Surgery. Recurrent topics in Paul Gow's work include Liver Disease and Transplantation (76 papers), Liver Disease Diagnosis and Treatment (72 papers) and Organ Transplantation Techniques and Outcomes (37 papers). Paul Gow is often cited by papers focused on Liver Disease and Transplantation (76 papers), Liver Disease Diagnosis and Treatment (72 papers) and Organ Transplantation Techniques and Outcomes (37 papers). Paul Gow collaborates with scholars based in Australia, United Kingdom and United States. Paul Gow's co-authors include Peter Angus, Marie Sinclair, Mathis Grossmann, Adam Testro, Rudolf Hoermann, David Mutimer, Roger W. Chapman, David Mutimer, Robert M. Jones and M Wali and has published in prestigious journals such as Gastroenterology, Journal of the American College of Cardiology and Hepatology.

In The Last Decade

Paul Gow

164 papers receiving 3.8k citations

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Paul Gow 2.2k 1.9k 945 628 405 173 3.9k
Anna Licata 1.6k 0.7× 2.0k 1.1× 743 0.8× 382 0.6× 139 0.3× 159 4.1k
Ronald L. Koretz 1.3k 0.6× 1.5k 0.8× 721 0.8× 705 1.1× 683 1.7× 125 3.2k
Stefano Ginanni Corradini 1.3k 0.6× 1.4k 0.7× 1.2k 1.3× 484 0.8× 257 0.6× 136 3.2k
Abdel Aziz Shaheen 2.2k 1.0× 3.3k 1.8× 1.6k 1.7× 535 0.9× 231 0.6× 114 5.6k
Laurie Blendis 1.0k 0.5× 1.4k 0.8× 779 0.8× 529 0.8× 193 0.5× 91 2.9k
Eduard Cabré 1.9k 0.9× 3.5k 1.9× 1.8k 1.9× 1.1k 1.7× 1.2k 2.8× 174 6.4k
Norberto C. Chávez‐Tapia 1.7k 0.8× 2.9k 1.5× 1.2k 1.2× 474 0.8× 194 0.5× 194 4.7k
Salvatore Badalamenti 1.9k 0.9× 1.7k 0.9× 1.5k 1.6× 203 0.3× 148 0.4× 97 4.0k
Andrés Duarte‐Rojo 4.0k 1.8× 3.9k 2.1× 1.2k 1.2× 1.7k 2.7× 420 1.0× 161 6.0k
Miguel Pérez‐Mateo 1.4k 0.7× 1.8k 1.0× 2.0k 2.1× 250 0.4× 127 0.3× 127 4.1k

Countries citing papers authored by Paul Gow

Since Specialization
Citations

This map shows the geographic impact of Paul Gow's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Paul Gow with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Paul Gow more than expected).

Fields of papers citing papers by Paul Gow

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Paul Gow. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Paul Gow. The network helps show where Paul Gow may publish in the future.

Co-authorship network of co-authors of Paul Gow

This figure shows the co-authorship network connecting the top 25 collaborators of Paul Gow. A scholar is included among the top collaborators of Paul Gow based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Paul Gow. Paul Gow is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Cailes, B., Numan Kutaiba, Omar Farouque, et al.. (2025). Abdominal aortic calcification on routine preoperative computed tomography—A novel cardiovascular risk prediction tool in liver transplant patients. Liver Transplantation. 31(12). 1522–1532.
2.
Hoermann, Rudolf, Marie Sinclair, Brooke Chapman, et al.. (2024). Branched‐chain amino acid supplementation does not improve measures of sarcopenia in cirrhosis: results of a randomised controlled trial. Alimentary Pharmacology & Therapeutics. 59(8). 941–952. 10 indexed citations
3.
Cailes, B., A. Koshy, Avik Majumdar, et al.. (2024). Impaired Cardiac Reserve is a Novel Predictor of Major Adverse Cardiovascular Events After Liver Transplantation. Heart Lung and Circulation. 33. S127–S128.
4.
Nicoll, Amanda, Jacob George, David Prince, et al.. (2024). Drug‐induced liver injury from selective androgen receptor modulators, anabolic‐androgenic steroids and bodybuilding supplements in Australia. Alimentary Pharmacology & Therapeutics. 59(8). 953–961. 3 indexed citations
5.
Fink, Michael, Paul Gow, Geoffrey W. McCaughan, et al.. (2023). Impact of Share 35 liver transplantation allocation in Australia and New Zealand. Clinical Transplantation. 38(1). e15203–e15203.
7.
Chapman, Brooke, Darren Wong, Marie Sinclair, et al.. (2023). Redefining Nutritional Requirements in End-Stage Liver Disease: Towards a Personalized Approach. Nutrients. 15(22). 4770–4770. 1 indexed citations
8.
Chapman, Brooke, Su Kah Goh, Frank Parker, et al.. (2022). Malnutrition and low muscle strength are independent predictors of clinical outcomes and healthcare costs after liver transplant. Clinical Nutrition ESPEN. 48. 210–219. 22 indexed citations
9.
Roberts, Stuart K., Ammar Majeed, John Lubel, et al.. (2022). Liver stiffness (Fibroscan®) is a predictor of all‐cause mortality in people with non‐alcoholic fatty liver disease. Liver International. 43(1). 90–99. 22 indexed citations
10.
Stutterd, Chloe, Alexa Kidd, Chris Florkowski, et al.. (2021). Expanding the clinical and radiological phenotypes of leukoencephalopathy due to biallelic HMBS mutations. American Journal of Medical Genetics Part A. 185(10). 2941–2950. 2 indexed citations
11.
Sawhney, Rohit, Siddharth Sood, Anouk Dev, et al.. (2020). SIRT Compared with DEB-TACE for Hepatocellular Carcinoma: a Real-world Study (the SITAR Study). Journal of Gastrointestinal Cancer. 52(3). 907–914. 4 indexed citations
12.
Koshy, A., A. Teh, Paul Gow, et al.. (2020). POST-OPERATIVE ATRIAL FIBRILLATION FOLLOWING LIVER TRANSPLANTATION AND ASSOCIATION WITH ADVERSE CARDIOVASCULAR EVENTS. Journal of the American College of Cardiology. 75(11). 198–198. 1 indexed citations
13.
Grigg, Sam, et al.. (2019). Systematic review with meta‐analysis: sirolimus‐ or everolimus‐based immunosuppression following liver transplantation for hepatocellular carcinoma. Alimentary Pharmacology & Therapeutics. 49(10). 1260–1273. 67 indexed citations
14.
Sinclair, Marie, et al.. (2019). Handgrip strength adds more prognostic value to the MELD score than imaging-based measures of muscle mass in men awaiting liver transplantation. Journal of Hepatology. 70(1). 1 indexed citations
15.
Gow, Paul, Michael Fink, Anouk Dev, et al.. (2018). Surveillance improves survival of patients with hepatocellular carcinoma: a prospective population‐based study. The Medical Journal of Australia. 209(8). 348–354. 43 indexed citations
16.
Cioccari, Luca, E Osawa, Kelly Jones, et al.. (2018). Outcome of Acetaminophen‐Induced Acute Liver Failure Managed Without Intracranial Pressure Monitoring or Transplantation. Liver Transplantation. 25(1). 35–44. 14 indexed citations
17.
Maćešić, Nenad, Iain J. Abbott, Matthew Kaye, et al.. (2017). Herpes simplex virus‐2 transmission following solid organ transplantation: Donor‐derived infection and transplantation from prior organ recipients. Transplant Infectious Disease. 19(5). 12 indexed citations
18.
Lubel, John, Peter Angus, & Paul Gow. (2007). Accidental paracetamol poisoning. The Medical Journal of Australia. 186(7). 371–372. 14 indexed citations
19.
Wali, M, Rebecca Harrison, Paul Gow, & David Mutimer. (2002). Advancing donor liver age and rapid fibrosis progression following transplantation for hepatitis C. Gut. 51(2). 248–252. 219 indexed citations
20.
Gow, Paul & David Mutimer. (2000). Mechanisms of hepatitis B virus escape after immunoglobulin therapy. Current Opinion in Infectious Diseases. 13(6). 643–646. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026